These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11464194)

  • 41. Clinical report: A patient with a late diagnosis of cerebrotendinous xanthomatosis and a response to treatment.
    Alhariri A; Hamilton K; Oza V; Cordoro K; Sobreira NL; Malloy M; Slavotinek A
    Am J Med Genet A; 2017 Aug; 173(8):2275-2279. PubMed ID: 28590052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes.
    Appadurai V; DeBarber A; Chiang PW; Patel SB; Steiner RD; Tyler C; Bonnen PE
    Mol Genet Metab; 2015 Dec; 116(4):298-304. PubMed ID: 26643207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cerebrotendinous xanthomatosis--a treatable metabolic disorder].
    Sperhake JP; Matschke J
    Nervenarzt; 2004 Jun; 75(6):608. PubMed ID: 15257383
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cerebrotendinous xanthomatosis. 2 cases with magnetic resonance imaging].
    Rogelet P; Gérard JM; Michotte A; Masingue M; Destée A
    Rev Neurol (Paris); 1992; 148(8-9):541-5. PubMed ID: 1494725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cerebrotendinous xanthomatosis: long-term treatment with chenodesoxycholic acid (author's transl)].
    Wolf LM; Houdent C; Laudat MH; Brasseur G; Balacheff O; Uzac L
    Nouv Presse Med; 1982 Mar; 11(11):855-7. PubMed ID: 7070978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cerebrotendinous xanthomatosis, a rare, severe, but treatable metabolic disorder].
    Delstanche S; Deflandre T; Otto B; Tshibanda L; Simoni P; Moonen G
    Rev Med Liege; 2013 Apr; 68(4):171-6. PubMed ID: 23755706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Imaging of cerebrotendinous xanthomatosis].
    Nagi S; Bouchriha M; Sebaï R; Marrakchi-Turki Z; Zouaoui W; Mrabet H; Megdiche H; Ben Slama C; Touibi S
    J Radiol; 2006 Dec; 87(12 Pt 1):1883-6. PubMed ID: 17213773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease.
    Rosafio F; Cavallieri F; Guaraldi P; Taroni F; Nichelli PF; Mandrioli J
    Clin Neurol Neurosurg; 2016 Apr; 143():1-3. PubMed ID: 26874936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
    Siman-Tov T; Meiner V; Gadoth N
    J Neurol Sci; 2006 Apr; 243(1-2):83-6. PubMed ID: 16445943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enlarging brain xanthomas in a patient with cerebrotendinous xanthomatosis.
    Brienza M; Fiermonte G; Cambieri C; Mignarri A; Dotti MT; Fiorelli M
    J Inherit Metab Dis; 2015 Sep; 38(5):981-2. PubMed ID: 25567502
    [No Abstract]   [Full Text] [Related]  

  • 51. Presenile cataract: consider cholestanol.
    Tészás A; Pfund Z; Morava E; Kosztolányi G; Sistermans E; Wevers RA; Kellermayer R
    Arch Ophthalmol; 2006 Oct; 124(10):1490-2. PubMed ID: 17030721
    [No Abstract]   [Full Text] [Related]  

  • 52. [Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis].
    Pilo de la Fuente B; Sobrido MJ; Girós M; Pozo L; Lustres M; Barrero F; Macarrón J; Díaz M; Jiménez-Escrig A
    Neurologia; 2011 Sep; 26(7):397-404. PubMed ID: 21345536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Berginer VM; Salen G; Shefer S
    N Engl J Med; 1984 Dec; 311(26):1649-52. PubMed ID: 6504105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two novel mutations in the sterol 27-hydroxylase gene causing cerebrotendinous xanthomatosis.
    Lamon-Fava S; Schaefer EJ; Garuti R; Salen G; Calandra S
    Clin Genet; 2002 Mar; 61(3):185-91. PubMed ID: 12000359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of LDL-apheresis on a case of Cerebrotendinous Xanthomatosis].
    Fukuo Y; Hayama N; Hara K; Terashi A; Seta K
    Rinsho Shinkeigaku; 1989 Feb; 29(2):196-201. PubMed ID: 2752648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis.
    Verrips A; van Engelen BG; Wevers RA; van Geel BM; Cruysberg JR; van den Heuvel LP; Keyser A; Gabreëls FJ
    Arch Neurol; 2000 Apr; 57(4):520-4. PubMed ID: 10768627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Teaching neuroimage: cerebrotendinous xanthomatosis.
    Mehta BP; Shmerling RH
    Neurology; 2008 Jul; 71(2):e4. PubMed ID: 18606959
    [No Abstract]   [Full Text] [Related]  

  • 58. A Treatable Rare Cause of Progressive Ataxia and Palatal Tremor.
    Rossi M; Cesarini M; Gatto EM; Cammarota A; Merello M
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():538. PubMed ID: 29971195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel frameshift mutation in the sterol 27-hydroxylase gene in an Egyptian family with cerebrotendinous xanthomatosis without cataract.
    Abdel-Hamid MS; Issa MY; Otaify GA; Zaki MS
    Metab Brain Dis; 2017 Apr; 32(2):311-315. PubMed ID: 28229379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrotendinous xanthomatosis presenting as "chologenic diarrhoea".
    Bindl L; Lütjohann D; Lentze MJ; von Bergmann K
    Acta Paediatr; 2001 Jul; 90(7):828-9. PubMed ID: 11519995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.